Decreased norepinephrine transporter availability in obesity: Positron Emission Tomography imaging with (S,S)-[11C]O-methylreboxetine
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Objectives Noradrenergic dysfunction is implicated in obesity. The norepinephrine transporter (NET) regulates the synaptic availability of norepinephrine. However, NET availability has not been previously characterized in vivo in obese people using Positron Emission Tomography (PET) imaging. Here we report findings evaluating NET availability in individuals with obesity and matched lean (i.e., normal weight) comparison subjects. Methods Seventeen obese but otherwise healthy individuals with a mean±SD body mass index (BMI) of 34.7±2.6 and 17 lean individuals with a mean±SD BMI of 23.1±1.4 were studied using a High-Resolution Research Tomograph (HRRT) and (S,S)-[11C]O-methylreboxetine ([11C]-MRB), a radioligand selective for the NET. The regional brain NET binding potential (BPND) was estimated by the multilinear reference tissue model 2 (MRTM2) with the occipital cortex as a reference region. BPND for regions of interest were obtained with the Automated Anatomic Labeling (AAL) template registered to individual’s structural MR scans. Results Obese individuals had lower NET BPND values in the thalamus (p<0.038, 27% reduction) including within the pulvinar (p<0.083, 30% reduction), but not in the hypothalamus, locus coeruleus or the raphe nuclei, compared to lean individuals. When age was included as a covariate, the difference in NET BPND values remained significant in the thalamus (p<0.025) and pulvinar (p<0.042). Conclusions These results indicate that NET availability is decreased in the thalamus, including the pulvinar, in obese individuals. These findings further support data indicating noradrenergic dysfunction in obesity and suggest impaired NE clearance in obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Houle, S., Huang, S.-C., Ichise, M., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600493 · Cited by 1,955
Self-citationWang, G.-J., Volkow, N. D., Logan, J., Pappas, N. R., Wong, C. T., Zhu, W., Netusll, N., & Fowler, J. S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03643-6 · Cited by 1,864 · cited 1×
“While catecholaminergic dysfunction in obesity has largely focused on dopamine (Frascella et al., 2010; Kenny, 2011; Volkow et al., 2013;Wang et al., 2001), data also support noradrenergic contributions (Carlsson, 1979).”
BackgroundChambers, R. A., Taylor, J. R., & Potenza, M. N. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.6.1041 · Cited by 1,719
Self-citationObesity and addiction: Neurobiological overlaps
Volkow, N. D., Wang, G. ‐., Tomasi, D., & Baler, R. D. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01031.x · Cited by 800 · cited 1×
“While catecholaminergic dysfunction in obesity has largely focused on dopamine (Frascella et al., 2010; Kenny, 2011; Volkow et al., 2013;Wang et al., 2001), data also support noradrenergic contributions (Carlsson, 1979).”
BackgroundReward mechanisms in obesity: new insights and future directions
Kenny, P. J. (2011) · Neuron · doi:10.1016/j.neuron.2011.02.016 · Cited by 748
Page, K. A., Chan, O., Arora, J., Belfort-DeAguiar, R., Dzuira, J., Roehmholdt, B., Cline, G. W., Naik, S., Sinha, R., Constable, R. T., et al. (2013) · JAMA · doi:10.1001/jama.2012.116975 · Cited by 379
Self-citationSleep restriction leads to increased activation of brain regions sensitive to food stimuli
St-Onge, M.-P., McReynolds, A., Trivedi, Z. B., Roberts, A. L., Sy, M., & Hirsch, J. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.027383 · Cited by 277 · cited 1×
“Restricted sleep increases cerebral responses to food cues in association with increased activity in the insula, striatum, thalamus, and prefrontal cortices (St-Onge et al., 2012).”
BackgroundHannestad, J., Gallezot, J.-D., Planeta-Wilson, B., Lin, S.-F., Williams, W. A., van Dyck, C. H., Malison, R. T., Carson, R. E., & Ding, Y.-S. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.017 · Cited by 236
Self-citationNeural Correlates of Stress- and Food Cue–Induced Food Craving in Obesity
Jastreboff, A. M., Sinha, R., Lacadie, C., Small, D. M., Sherwin, R. S., & Potenza, M. N. (2013) · Diabetes Care · doi:10.2337/dc12-1112 · Cited by 204 · cited 2×
“Furthermore, the relationship between insulin resistance and food craving in obese but not lean individuals was mediated by thalamic activation during exposure to favorite-food cues (Jastreboff et al., 2013).”
BackgroundSelf-citation
Cited by
Hansen, J. Y., Shafiei, G., Markello, R. D., Smart, K., Cox, S. M. L., Nørgaard, M., Beliveau, V., Wu, Y., Gallezot, J.-D., Aumont, É., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01186-3 · Cited by 797
“, 2010 [11, 19, 27, 101] 5-HT1A serotonin [(11)C]WAY-100635 BPND 36 26.”
Self-citationHansen, J. Y., Markello, R. D., Tuominen, L., Nørgaard, M., Kuzmin, E., Palomero-Gallagher, N., Dagher, A., & Misic, B. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119671 · Cited by 69
Ulke, C., Rullmann, M., Huang, J., Luthardt, J., Becker, G.-A., Patt, M., Meyer, P. M., Tiepolt, S., Hesse, S., Sabri, O., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0619-y · Cited by 43
(n.d.) · Progress in Neuro-Psychopharmacology and Biological Psychiatry / PsyPost · doi:10.1016/j.pnpbp.2026.111679
Metadata
- Authors
- Li, C.-S. R., Potenza, M. N., Lee, D. E., Planeta, B., Gallezot, J.-D., Labaree, D., Henry, S., Nabulsi, N., Sinha, R., Ding, Y.-S., Carson, R. E., & Neumeister, A.
- Venue
- NeuroImage
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 86
- Pages
- 306-310
- ISSN
- 1053-8119 (ISSN-L)
- OpenAlex
- W2097444564
- Cited by
- 68
- References
- 9
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Decreased norepinephrine transporter availability in obesity: Positron Emission Tomography imaging with (S,S)-[11C]O-methylreboxetine. https://app.cochat.ai/papers/10.1016/j.neuroimage.2013.10.004
- The paper
- Li, C.-S. R., Potenza, M. N., Lee, D. E., Planeta, B., Gallezot, J.-D., Labaree, D., Henry, S., Nabulsi, N., Sinha, R., Ding, Y.-S., Carson, R. E., & Neumeister, A. (2014). Decreased norepinephrine transporter availability in obesity: Positron Emission Tomography imaging with (S,S)-[11C]O-methylreboxetine. NeuroImage. https://doi.org/10.1016/j.neuroimage.2013.10.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.